Using the proprietary affinity resin derived from the Veritope Technology, Abreos can offer competitive speed, performance, and product resolution at a well-defined cost and time reduction that will enable bioprocess programs to optimize affinity purification for any class of biopharmaceuticals.

Abreos custom-made, molecule-specific resins enable high yield and purity for antibodies and therapeutic proteins. This selection allows assets to be improved in purity, potency, and safety. 

Using Abreos peptide-based affinity ligands delivers robust binding, cleaning, and sanitation stability in early discovery and development phases that help improve downstream manufacturability through commercialization.